Search research articles
Contact Us
Filters
Showing results (491-500 of 514) with videos related to
Page
of 52
Sort By:
European Urology Oncology
|
December 16, 2025
Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy
Federico Mastroleo, Riccardo Villa, Mattia Zaffaroni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 2024
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation
Giuseppe Sanguineti, Maddalena Pavarini, Fernando Munoz, et al.
European Urology
|
June 24, 2023
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study
Felix Preisser, Raisa S Abrams-Pompe, Piter Jan Stelwagen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 4, 2025
Predictors of toxicities and oncological outcomes following postoperative ablative radiotherapy (POPART) for biochemical recurrence
Federica Ferrario, Ciro Franzese, Suela Vukcaj, et al.
World Journal of Urology
|
March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
BJR Open
|
March 25, 2024
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial
Marco Lorenzo Bonù, Alessandro Magli, Davide Tomasini, et al.
Cancer Research Communications
|
March 28, 2024
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 25, 2025
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study - ATLANTIS part I
Luca Nicosia, Marco Lorenzo Bonù, Ilaria Angelicone, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 19, 2025
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies
Karim Azzag, Alessandro Magli, James Kiley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 19, 2024
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer
Maddalena Pavarini, Lisa Alborghetti, Stefania Aimonetto, et al.
Page
of 52
Search research articles
Search
Showing results (491-500 of 514) with videos related to
Sort By:
Page
of 52
European Urology Oncology
|
December 16, 2025
Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy
Federico Mastroleo, Riccardo Villa, Mattia Zaffaroni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 2024
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation
Giuseppe Sanguineti, Maddalena Pavarini, Fernando Munoz, et al.
European Urology
|
June 24, 2023
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study
Felix Preisser, Raisa S Abrams-Pompe, Piter Jan Stelwagen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 4, 2025
Predictors of toxicities and oncological outcomes following postoperative ablative radiotherapy (POPART) for biochemical recurrence
Federica Ferrario, Ciro Franzese, Suela Vukcaj, et al.
World Journal of Urology
|
March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
BJR Open
|
March 25, 2024
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial
Marco Lorenzo Bonù, Alessandro Magli, Davide Tomasini, et al.
Cancer Research Communications
|
March 28, 2024
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 25, 2025
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study - ATLANTIS part I
Luca Nicosia, Marco Lorenzo Bonù, Ilaria Angelicone, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 19, 2025
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies
Karim Azzag, Alessandro Magli, James Kiley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 19, 2024
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer
Maddalena Pavarini, Lisa Alborghetti, Stefania Aimonetto, et al.
Page
of 52